Wentao Lu

Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials

G. Raskob, W. Ageno, J. Halperin, 2022, Circulation.

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

G. Raskob, W. Ageno, J. Halperin, 2020, Journal of the American College of Cardiology.

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

G. Raskob, W. Ageno, E. Barnathan, 2021, Journal of the American Heart Association.

Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER

G. Raskob, E. Barnathan, B. Levitan, 2021, Journal of the American Heart Association.

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

G. Raskob, W. Ageno, J. Halperin, 2022, TH Open.

Thromboprophylaxis for Children Post‐Fontan Procedure: Insights From the UNIVERSE Study

B. McCrindle, A. Michelson, Jennifer S. Li, 2021, Journal of the American Heart Association.

Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness

G. Raskob, W. Ageno, J. Halperin, 2022, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older

G. Raskob, W. Ageno, J. Halperin, 2021, Journal of thrombosis and haemostasis : JTH.

Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study

G. Raskob, E. Barnathan, C. Lipardi, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials

G. Raskob, E. Barnathan, C. Lipardi, 2020, Thrombosis and Haemostasis.

Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study

G. Raskob, A. Mebazaa, E. Barnathan, 2022, TH open : companion journal to thrombosis and haemostasis.

Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis

G. Raskob, E. Barnathan, C. Lipardi, 2021, Clinical and applied thrombosis/hemostasis.